Page last updated: 2024-08-26

fulvestrant and calcitriol

fulvestrant has been researched along with calcitriol in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (22.22)18.2507
2000's4 (44.44)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Binderup, L; Colston, KW; James, SY; Mackay, AG1
Barto, R; Netelenbos, JC; Ten Bolscher, M; Van Buuren, LM; Van der vijgh, WJ1
Bogart, DF; Li, P; Lupu, R; Mehmi, I; Tsai, MS1
Chaumaz, G; Cournot, G; Lieberherr, M; Pointillart, A; Rassi, CM1
Christensen, GL; Christensen, IJ; Fog, CK; Jepsen, JS; Lykkesfeldt, AE1
Astudillo, P; Fernández, M; Leiva, L; Pino, AM; Ríos, S; Rodríguez, JM; Rodríguez, JP; Seitz, G1
Avila, E; Barrera, D; Camacho, J; Díaz, L; Esparza-López, J; García-Becerra, R; García-Quiroz, J; Halhali, A; Ibarra-Sánchez, MJ; Larrea, F; Medina-Franco, H; Ordaz-Rosado, D; Santos-Martínez, N1

Reviews

1 review(s) available for fulvestrant and calcitriol

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

8 other study(ies) available for fulvestrant and calcitriol

ArticleYear
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
    Toxicological sciences : an official journal of the Society of Toxicology, 2013, Volume: 136, Issue:1

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests

2013
Effects of a new synthetic vitamin D analogue, EB1089, on the oestrogen-responsive growth of human breast cancer cells.
    The Journal of endocrinology, 1994, Volume: 141, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Division; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Humans; Receptors, Estrogen; Time Factors; Tumor Cells, Cultured

1994
Estrogen regulation of intestinal calcium absorption in the intact and ovariectomized adult rat.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 1999, Volume: 14, Issue:7

    Topics: Animals; Calcitriol; Calcium; Duodenum; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Intestinal Absorption; Ovariectomy; Rats; Rats, Wistar; Receptors, Estrogen

1999
Expression and regulation of Cyr61 in human breast cancer cell lines.
    Oncogene, 2002, Jan-31, Volume: 21, Issue:6

    Topics: Active Transport, Cell Nucleus; Adenocarcinoma; Breast Neoplasms; Calcitriol; Cysteine-Rich Protein 61; Drug Resistance; Estradiol; Estrogen Receptor Modulators; Estrogens; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Genes, Immediate-Early; Growth Substances; Humans; Immediate-Early Proteins; Intercellular Signaling Peptides and Proteins; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms, Hormone-Dependent; Phenotype; Protein Structure, Tertiary; Receptors, Estrogen; RNA, Messenger; RNA, Neoplasm; Selective Estrogen Receptor Modulators; Tamoxifen; Tetradecanoylphorbol Acetate; Transcriptional Activation; Transfection; Tretinoin; Tumor Cells, Cultured

2002
Down-regulation of osteoclast differentiation by daidzein via caspase 3.
    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2002, Volume: 17, Issue:4

    Topics: Acid Phosphatase; Animals; Apoptosis; Bone Marrow Cells; Calcitriol; Caspase 3; Caspases; Cell Differentiation; Cells, Cultured; Down-Regulation; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens, Non-Steroidal; Female; Fulvestrant; Isoenzymes; Isoflavones; Osteoclasts; Receptors, Estrogen; Swine; Tartrate-Resistant Acid Phosphatase

2002
Sequential versus combined treatment of human breast cancer cells with antiestrogens and the vitamin D analogue EB1089 and evaluation of predictive markers for vitamin D treatment.
    Breast cancer research and treatment, 2004, Volume: 85, Issue:1

    Topics: Antineoplastic Agents; Breast Neoplasms; Calcitriol; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Therapy, Combination; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Fulvestrant; Genes, bcl-2; Humans; Predictive Value of Tests; Receptors, Calcitriol; Receptors, Estrogen; Tamoxifen; Vitamin D

2004
Aromatase activity of human mesenchymal stem cells is stimulated by early differentiation, vitamin D and leptin.
    The Journal of endocrinology, 2006, Volume: 191, Issue:3

    Topics: Adipocytes; Aged; Aged, 80 and over; Analysis of Variance; Aromatase; Aromatase Inhibitors; Blotting, Western; Bone Marrow Cells; Cell Differentiation; Cells, Cultured; Enzyme Activation; Estradiol; Estrogen Antagonists; Estrogens; Female; Fulvestrant; Humans; Leptin; Mesenchymal Stem Cells; Microscopy, Fluorescence; Osteoblasts; Vitamin D

2006
Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
    BMC cancer, 2014, Mar-29, Volume: 14

    Topics: Breast Neoplasms; Calcitriol; Cell Line, Tumor; Cyclin D1; Estradiol; Estrogen Receptor alpha; Estrogen Receptor Modulators; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Receptors, Calcitriol

2014